Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ZW49 |
| Trade Name | |
| Synonyms | ZW-49|ADC ZW49 |
| Drug Descriptions |
ZW49 is an antibody-drug conjugate (ADC) comprising a bispecific ERBB2 (HER2) antibody linked to auristatin, which delivers the cytotoxic agent to ERBB2 (HER2)-expressing cells, potentially resulting in cell growth inhibition and tumor regression (Cancer Res 2019;79(4 Suppl):Abstract nr P6-17-13). |
| DrugClasses | HER2 (ERBB2) Antibody 79 HER2 (ERBB2) Antibody-Drug Conjugate 35 |
| CAS Registry Number | NA |
| NCIT ID | C162115 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ZW49 | ZW49 | 0 | 1 |